Notice Number: NOT-RM-18-020

Key Dates
Release Date: August 1, 2018

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

The NIH will hold a pre-application interactive Q&A webinar for the Somatic Cell Genome Editing (SCGE) program (https://commonfund.nih.gov/editing). NIH staff will discuss the following funding opportunities and answer questions from prospective applicants:

• Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 - Clinical Trial Not Allowed) (RFA-RM-18-022)
• Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-18-023)
• Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) (RFA-RM-18-024)
• Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trials Not Allowed) (RFA-RM-18-025)

Webinar Information:

Date/Time: August 14, 2018 from 12p-2p ET

Link for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e763511456612dd9acf0dde40160eff07

Call-in toll number (US/Canada): 1-650-479-3208

Event number: 627 840 766

Event password: SCGE2018

Inquiries

Please direct all inquiries to:

P.J. Brooks, Ph.D.
National Center for Advancing Translational Sciences
Telephone: 301-443-0513
Email: SCGEprogram@nih.gov